39

DAFTAR PUSTAKA
1. Daly JP. Malaria. Dalam: Gershon AA, Hotez PJ, Katz SL, penyunting. Krugmans
infectious diseases of children. Edisi ke-11. Philadelphia: Mosby;2004.h.337-51
2. Greenwood BM, Bojang K, Whitty CJ, Targett GA. Malaria. Lancet.2005; 365:1487-
98
3. Direktorat Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan. Pedoman
tatalaksana kasus malaria di Indonesia. Jakarta: Departemen Kesehatan RI; 2005
4. World Health Organization. Malaria in SEAR countries. Diunduh dari :
http://www.searo.who.int/en/Section10/Section21/Section340_4022.htm. Diakses
April 2010
5. Taylor TE, Strickland GT. Malaria. Dalam: Strickland GT, penyunting. Hunters
tropical medicine and emerging infectious diseases. Edisi ke-8. Philadelphia:
Saunders; 2000.h.614-41
6. World Health Organization. Guidelines for the treatment of malaria.Switzerland:
World Health Organization; 2006
7. Hastings IM, Korenromp EL, Bloland PB. The anatomy of a malaria disaster: drug
policy choice and mortality in african children. Lancet Infect Dis. 2007;7:739-48
8. Pasaribu S, Pasaribu AP, Lubis CP. Combination of artesunate-amodiaquine as a
treatment for uncomplicated falciparum malaria in children. Pediatrics.
2008;121:S133
9. Marfurt J, Mueller I, Sie A, Maku P, Goroti M, Reeder JC, dkk. Low efficacy of
amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against plasmodium
falciparum and P. vivax malaria in Papua New Guinea. Am J Trop Med Hyg.
2007;77(5):947-54
10. Mutabingwa TK, Anthony D, Heller A, Hallet R, Ahmed J, Drakeley C, dkk.
Amodiaquine alone, amodiaquine+sulfadoxine pyrimethamine,
amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of
malaria in Tanzanian children: a four-arm randomized effectiveness trial. Lancet.
2005;365:1474-80
11. Adjei GO, Goka BQ, Rodrigues OP, Hoegberg LCG, Alifrangis M, Kurtzhals AL.
Amodiaquine associated adverse effects after inadvertent overdose and after a
standard therapeutic dose. Ghana Med J. 2009;43:135-8
12. Guthman JP, Cohuet S, Rigutto C, Fortes F, Saraiva N, Kiguli J, dkk. Short report:
high efficacy of two arteminin-based combinations (artesunate+amodiaquine and
artemether-lumefantrine) in Caala, Central Angola. Am J Trop Med Hyg.
2006;75:143-5
13. Dorsey G, Satedke S, Clark TD, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C,
dkk. Combination therapy for uncomplicated falciparum malaria in Ugandan
children.JAMA.2007;297:2210-9
14. Ratciff A, Siswantoro H, Kenangalem E, Maristela R, Wuwung RM, Laihad F, dkk.
Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax
Universitas Sumatera Utara
40
malaria in Papua, Indonesia: an open-label randomised comparison. Lancet.2007;
369: 75765
15. Krogstad DJ. Plasmodium species (malaria). Dalam: Mandell GL, Bennet JE,
Raphael D, penyunting. Mandell, Douglas, and Bennetts principles and practice of
infectious diseases. Philadephia: Churcill Livingstone; 2000.h.2817-31
16. Singh B, Sung LK, Metusop A, Radhakrishnan A, Shamsul SS, Singh JC, dkk. A
large focus of naturally acquired Plasmodium knowlesi infections in human beings.
Lancet. 2004; 363: 1017-24
17. Ng OT, Eong OE, Chuan LC, Jarrod LP, Ching NL, Wong PS, dkk. Naturally
acquired human Plasmodium knowlesi infection, Singapore. Emerg Infect Dis; 2008:
1-7
18. Soedarmo SS, Garna H, Hadinegoro SR, Satari HI. Malaria. Dalam: Buku ajar
infeksi dan pediatrik tropis. Edisi ke-2. Jakarta: IDAI;2008.h.408-37
19. Lema OE, Carter JY, Nagelkerke N, Wangal MW, Kitenge P, Gikunda SM, dkk.
Comparison of five methods of malaria detection in the outpatient setting. Am J Trop
Med Hyg; 1999: 177-82
20. Susanto I, Pribadi W. Parasit malaria. Dalam: Susanto I, Ismid IS, Sjarifuddin PK,
Sungkar S, penyunting. Buku ajar parasitologi kedokteran. Jakarta: Balai Penerbit
FKUI; 2008. h. 189-221
21. World Health Organization. Antimalarial combination drug therapy. Report of a WHO
technical consultation. Geneva: WHO; 2001
22. Kobbe R, Klein P, Adjei S, Amemasor S, Thompson WN, Heidemann H, dkk. A
randomized trial on effectiveness of artemether-lumefantrine versus artesunate plus
amodiaquine for unsupervised treatment of uncomplicated plasmodium falciparum
malaria in Ghanaian children. Malar J. 2008: 7: 261
23. Maiteki-Sebuguzi C, Jagannathan P, Yau VM, Clark TD, Njama-Meya D, Nzarubara
B, dkk. Safety and tolerability of combination antimalarial therapies for
uncomplicated falciparum malaria in Ugandan children. Malar J. 2008;7:106
24. Krishna S, Uhlemann AC, Haynes RK. Artemisinins: mechanisms of action and
potential for resistance. Drug Resist Updates.2004;7:233-44
25. Newton P, Suputtamongkol Y, Isavadharm PT, Pukrittayakamee S, Navaratnam V,
Bates I, dkk. Antimalarial bioavaibility and disposition of artesunate in acute
falciparum malaria. Antimicrob Agents Chemother; 2000: 972-7
26. Adjuik M, Agnamey P, Babiker A, Borrman S, Brasseur P, Cisse M, dkk.
Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium
falciparum malaria in African children: a randomized, multicentre trial. Lancet. 2002;
359: 1365-72
27. Martensson A, Stromberg J, Sisowath C, Msellem MI, Gil P, Montgomery SM, dkk.
Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for
the treatment of uncomplicated childhood Plasmodium falciparum malaria in
Zanzibar,Tanzania. Clin Inf Dis.2005;41:1079-86
28. Asante KP, Owusu R, Dosoo D, Awini E, Adjei G, Etego SA, dkk. Adherence to
artesunate-amodiaquine therapy for uncomplicated malaria in rural Ghana: a
randomized trial of supervised versus unsupervised drug administration. J Trop Med.
2009: 1-7
Universitas Sumatera Utara
41
29. Makanga M, Krudsood S. The clinical efficacy of artemether/lumefantrine (coartem).
Malaria J. 2009;8 (Supp I):S5-9
30. Djimde A, Lefevre G. Understanding the pharmacokinetics of coartem. Malar J;
2009: S1-4
31. Faye B, Ndiaye JL, Ndiaye D, Dieng Y, Faye O, Gaye O. Efficacy and tolerability of
four antimalarial combinations in the treatment of uncomplicated Plasmodium
falciparum malaria in Senegal. Malar J. 2007;6:80-8
32. Madiyono B, Moechlisan S, Sastroasmoro S, Budiman I, Purwanto SH. Perkiraan
besar sampel. Dalam: Sastroasmoro S, Ismail S, penyunting. Dasar-dasar
metodologi penelitian klinis. Edisi ke-3. Jakarta: Sagung Seto;2008.h.302-30
33. Adjei GO, Kudzi W, Dodoo A, Kurtzhals JAL. Artesunate plus amodiaquine
combination therapy: reviewing the evidence. Drug Dev Res. 2010;71:33-43
34. World Health Organization. Assessment and monitoring of antimalarial drug efficacy
for the treatment of uncomplicated falciparum malaria. Geneva: WHO; 2003
35. Azlin E, Batubara I, Dalimunthe W, Siregar C, Lubis B, Lubis M, dkk. The
effectiveness of chloroquine compared to fansidar in treating falciparum malaria.
Pediatr Indones.2004; 44: 17-20
36. Munif A, Imron M. Panduan pengamatan nyamuk vektor malaria. Jakarta: Sagung
Seto; 2010
37. Marsaulina I. Tempat perkembangbiakan anopheles sundaicus di desa Sihepeng,
kecamatan Siabu, Kabupaten Mandailing Natal, Propinsi Sumatera Utara. Info
Kesehatan Masyarakat. 2008;12(2):119-23
38. Deribew A, Alemseged F, Tessema F, Sena L, Birhanu Z, Zeynudin A, dkk. Malaria
and under-nutrition: a community based study among under-five children at risk of
malaria, South-West Ethiopia. PLoS ONE.2010;5(5):e10775
39. Crookston BT, Alder SC, Boakye I, Merill RM, Amuasi JH, Porucznik CA, dkk.
Exploring the relationship between chronic undernutrition and asymptomatic malaria
in Ghanaian children. Malar J. 2010;9:39
40. Nyakeriga AM, Troye-Blomberg M, Chemtai AK, Marsh K, Williams TN. Malaria and
nutritional status in children living on the coast of Kenya. Am J Clin Nutr.
2004;80:1604-10
41. Nurjaya IO. Status gizi dan kepadatan penyakit malaria pada anak usia sekolah
dasar di daerah endemis malaria.[tesis].Semarang:Program Pendidikan Dokter
Spesialis I Ilmu Kesehatan Anak FKUNDIP, 2004
42. Grobusch MP, Kremsner PG. Uncomplicated malaria. CTMI.2005;295:83-104
43. Sowunmy A. Hepatomegaly in acute falciparum malaria in children. Trans R Soc
Trop Med Hyg.1996;90(5):540-2
44. Pasaribu S, Lubis CP. The correlation between parasitemia and spleen size in
children with falciparum malaria.e-USU Repository.2004 [diakses bulan Oktober
2011]. Diunduh dari: http://library.usu.ac.id/download/fk/anak-chairuddin20.pdf
45. Zwang J, Olliaro P, Barennes H, Bonnet M, Brasseur P, Bukirwa H, dkk. Efficacy of
artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-
Saharan Africa: a multi-centre analysis. Malar J. 2009;8:203
Universitas Sumatera Utara
42
46. Nawaz F, Nsobya SL, Kiggundu M, Joloba M, Rosenthal PJ. Selection of parasites
with diminished drug sensitivity by amodiaquine-containing antimalarial regimens in
Uganda. J Infect Dis. 2009;200(11):1650-7
47. Sa JM, Twu O, Hayton K, Reyes S, Fay MP, Ringwald P, dkk. Geographic patterns
of plasmodium falciparum drug resistance distinguished by differential responses to
amodiaquine and chloroquine. Proc Natl Acad Sci USA. 2009;106(45):18883-9
48. Pasaribu AP, Yuliati E, Lubis M, Pasaribu S, Lubis CP. Efficacy of artesunate-
amodiaquine and quinine-azithromycin combination in treatment of uncomplicated
falciparum malaria in children. Majalah Kedokteran Nusantara. 2008;41(4):228-34
49. Fitri P, Armila, Lubis M, Pasaribu S, Lubis CP. Comparison of the efficacy of
artesunate-amodiaquine with quinine-clindamycin for treatment of uncomplicated
falciparum malaria in children. Paediatr Indones. 2009;49(2):91-6
50. Ndiaye JL, Randrianarivelojosia M, Sagara I, Brasseur P, Ndiaye I, Faye B, dkk.
Randomized, multicentre assessment of the efficacy and safety of ASAQ a fixed-
dose artesunate-amodiaquine combination therapy in the treatment of
uncomplicated Plasmodium falciparum malaria. Malar J.2009:8;125
51. Silvana S. Efikasi monoterapi artesunate dengan gabungan artesunate-amodiakuin
pada pengobatan malaria falsiparum tanpa komplikasi pada anak.[tesis]. Medan:
Program Magister Kedokteran Klinik-Spesialis Ilmu Kesehatan Anak FKUSU, 2008
52. Falade C, Manyando C. Safety profile of coartem: the evidence base. Malar J.
2009;8:1-6
53. Ezzet F, Vugt MV, Nosten F, Looareesuwan S, White NJ. Pharmacokinetics and
pharmacodynamics of lumefantrine (benflumetol) in acute falciparum. Antimicrob
Agents Microbs. 2000;44(3):697-704
54. Owusu-Agyei S, Asante KP, Owusu R, Adjuik M, Amenga-Etego S, Dosoo DK, dkk.
An open label, randomized trial of artesunate+amodiaquine,
artesunate+chlorproguanil-dapsone and artemether-lumefantrine for the treatment of
uncomplicated malaria. PLoS ONE. 2008;3(6): e2530-7
55. Rachmawati, Rampengan NH, Tatura SNN, Rampengan TH. Comparison of the
efficacy of artemether-lumefantrine vs artesunate plus sulfadoxine-pyrimethamine in
children with uncomplicated falciparum malaria. Paediatr Indones. 2010;50(2):113-7
56. Michael OS, Gbotosho GO, Folarin OA, Okuboyejo T, Sowunmi A, Oduola AM, dkk.
Early variations in plasmodium falciparum dynamics in Nigerian children after
treatment with two artemisinin-based combinations: implications on delayed parasite
clearance. Malar J.2010; 9: 335-43
57. Sowunmi A, Adewoye EO, Gbotsho GO, Happi CT, Sijuade A, dkk. Factors
contributing to delay in parasite clearence in uncomplicated falciparum malaria in
children. Malar J. 2010;9:53-64
58. Meremikwu MM, Logan K, Garner P. Antipyretic measures for treating fever in
malaria (review). Cochrane Database Syst Rev. 2009;1:1-15
59. Kabanywanyi AM, Mwita A, Sumari D, Mandike R, Mugittu K, Abdulla S. Efficacy
and safety of artemisinin-based antimalarial in the treatment of uncomplicated
malaria in Southern Tanzania. Malar J.2007; 6:146-50
Universitas Sumatera Utara
43
60. Whegang SY, Tahar R, Foumane VN, Soula G, Gwet H, Thalabard J, dkk. Efficacy
of non-artemisinin and artemisinin-based combination therapies for uncomplicated
falciparum malaria in Cameroon. Malar J.2010; 9:56-66
Universitas Sumatera Utara